world
war
ii
malaria
case
per
year
report
japan
includ
indigen
import
induc
malaria
malaria
success
erad
sinc
japan
import
malaria
case
encount
howev
number
japanes
peopl
go
abroad
also
number
foreign
visit
japan
increas
million
respect
chanc
japanes
doctor
see
import
malaria
transfusiontransmit
malaria
case
fact
total
number
patient
acut
malaria
japan
around
annual
last
year
japanes
foreign
male
femal
peak
age
recent
patient
plasmodium
falciparum
anoth
plasmodium
vivax
infect
former
speci
like
seen
travel
come
back
african
countri
latter
mainli
asian
countri
import
issu
patient
japan
diagnos
promptli
treat
properli
doctor
japan
longer
familiar
tropic
medicin
therefor
patient
die
sever
malaria
consequ
effect
medicin
drugresist
malaria
sever
malaria
regist
japan
need
medic
practition
focu
travel
medicin
japan
world
war
ii
malaria
case
includ
indigen
import
transfus
malaria
report
accord
surveil
statist
ministri
health
welfar
current
ministri
health
labour
welfar
mhlw
japan
owe
dedic
effort
made
communitybas
malaria
control
program
local
set
japan
indigen
malaria
erad
sinc
ishigaki
citi
offic
time
japanes
economi
grew
densiti
respons
mosquito
transmiss
anophel
sinensi
anophel
minimu
decreas
promot
hygien
howev
malaria
situat
endem
area
particularli
develop
countri
tropic
improv
dramat
fact
report
wors
partli
emerg
drugresist
malaria
insecticid
resist
mosquito
deterior
current
malaria
situat
also
caus
global
environment
chang
popul
movement
mani
peopl
travel
malari
area
visit
friend
rel
come
back
region
countri
malaria
consequ
spread
malaria
big
burden
peopl
malari
area
also
nonmalari
area
schlagenhauf
japan
except
problem
number
intern
travel
fromto
japan
steadili
increas
japanes
peopl
travel
abroad
foreign
citizen
came
japan
result
fewer
import
malaria
case
report
annual
sinc
ohtomo
takeuchi
higher
incid
fatal
report
develop
countri
also
seen
japan
prompt
proper
diagnosi
treatment
readili
institut
physician
articl
review
current
trend
import
malaria
case
japan
side
effect
chloroquin
retinopathi
among
chronic
user
renal
diseas
administr
drug
prohibit
malaria
patient
well
sinc
oral
quinin
licens
drug
malaria
decad
order
conquer
situat
shortag
avail
drug
japan
treatment
malaria
tropic
diseas
research
group
chemotherapi
tropic
diseas
establish
sinc
support
grant
mhlw
last
fansidar
pyrimethamin
sulfadoxin
regist
japan
quit
recent
octob
mephaquin
ss
tablet
mefloquin
allow
market
japan
result
continu
effort
research
group
research
group
import
nonregist
antimalari
obtain
permiss
use
orphan
drug
mhlw
check
qualiti
nation
institut
health
scienc
clear
japanes
good
manufactur
practic
standard
drug
distribut
research
group
member
hospit
univers
throughout
japan
malaria
patient
access
readi
drug
antimalari
chloroquin
primaquin
inject
quinin
artesun
iv
oralrectalintramusclarintraven
atovaquoneproguanil
artemetherlumefantrin
web
page
research
group
use
one
http
wwwimsutokyoacjpdidaiorphan
present
japanes
research
group
analyz
demograph
data
togeth
questionnairebas
studi
import
malaria
case
purpos
travel
destin
period
travel
prophylact
antimalari
use
initi
diagnosi
made
chief
complaint
present
past
histori
speci
parasit
infect
laboratori
data
hospit
ask
compil
research
group
also
collect
data
efficaci
advers
effect
drug
use
tabl
show
number
malaria
case
year
case
identifi
annual
foreign
visitor
peopl
come
india
largest
number
follow
philippin
highest
number
fatal
observ
number
death
four
data
shown
increas
number
japanes
travel
african
countri
nowaday
proport
falciparum
malaria
case
seem
gradual
increas
trend
illustr
fig
proport
falciparum
malaria
patient
becam
compar
vivax
patient
avail
data
japanes
patient
show
nearli
threefourth
suffer
falciparum
malaria
data
shown
trend
malaria
treatment
analyz
precis
report
one
present
author
kimura
et
al
briefli
mefloquin
use
treatment
case
wherea
becom
wide
use
surpris
artesun
administ
initi
total
number
patient
april
new
law
call
law
concern
prevent
infecti
diseas
medic
care
patient
infecti
diseas
effect
law
revis
enact
quit
outdat
year
applic
new
law
infecti
diseas
categor
five
group
accord
sever
infect
group
consist
seven
diseas
name
ebola
hemorrhag
fever
lassa
fever
crimeancongo
hemorrhag
fever
marburg
diseas
pest
plagu
sever
acut
respiratori
syndrom
sar
smallpox
group
six
diseas
name
typhoid
fever
paratyphoid
fever
diphtheria
cholera
bacillari
dysenteri
shigellosi
acut
poliomyel
polio
group
escherichia
coli
diarrhea
group
current
made
diseas
includ
vectorborn
diseas
malaria
yellow
fever
west
nile
fever
group
diseas
ie
amoebiasi
syphili
influenza
anoth
categori
new
infecti
diseas
includ
emerg
infecti
diseas
human
be
never
contract
new
law
malaria
one
diseas
report
governor
physician
diagnos
patient
within
day
report
system
simplifi
revis
law
submit
questionnair
follow
question
ask
sex
age
diagnosi
made
microscop
serolog
symptomat
instrument
descript
chief
complaint
date
onset
date
admiss
hospit
date
definit
diagnosi
suspect
date
contract
date
death
patient
alreadi
dead
diagnos
place
resid
last
year
suspect
place
malaria
acquir
possibl
bitten
mosquito
suspect
rout
infect
friend
rel
around
complain
similar
symptom
time
questionnair
identifi
patient
even
know
hisher
citizenship
doctor
ask
submit
slide
smear
patient
recheck
expert
therefor
suspect
might
misdiagnosi
decid
speci
fact
symptomat
diagnos
malaria
case
report
without
know
whether
patient
show
parasitemia
sever
patient
fulli
describ
drug
use
treatment
report
outcom
known
howev
number
case
report
increas
new
law
doctor
report
case
punish
fine
japanes
yen
around
mhlw
japan
announc
annual
number
malaria
case
report
ministri
fig
seem
report
system
work
effect
previou
law
revis
number
patient
half
report
research
group
year
tabl
nation
epidemiolog
surveil
infecti
diseas
nesid
new
law
conduct
nation
institut
infecti
diseas
niid
number
malaria
case
offici
report
tabl
niid
idcd
niid
largest
number
malaria
patient
ever
report
may
reflect
new
regul
report
system
howev
annual
number
japanes
peopl
fig
highest
incid
observ
late
trend
observ
everi
year
young
patient
whose
age
like
infect
summer
vacat
august
septemb
data
shown
niid
first
report
transfusiontransmit
malaria
japan
describ
sakai
includ
two
vivax
malaria
case
one
boy
receiv
ml
whole
blood
father
auxiliari
treatment
bacillari
dysenteri
boy
receiv
total
ml
whole
blood
father
auxiliari
treatment
pertussi
total
case
transfus
malaria
report
world
war
ii
blood
donor
patient
parent
paid
blood
donor
includ
takada
nakayama
wartim
paid
blood
donor
like
veteran
come
back
tropic
pacif
area
malaria
endem
cours
possibl
transfusiontransmit
malaria
well
known
medic
technician
day
systemat
way
identifi
infecti
blood
war
preserv
blood
mainli
use
transfus
increas
chanc
infect
first
case
preserv
blood
transfusiontransmit
malaria
report
man
receiv
total
ml
blood
lung
surgeri
takada
twentytwo
transfus
malaria
case
world
war
ii
summar
ito
et
al
report
also
total
number
report
transfusiontransmit
malaria
case
japan
plasmodium
falciparum
case
plasmodium
vivax
case
plasmodium
oval
case
case
unknown
speci
platelet
transfusiontransmit
malaria
report
woman
patient
suffer
thrombocytopenia
unsuccess
treat
consequ
kano
suzuki
case
last
case
transfusiontransmit
malaria
case
japan
report
transfus
case
far
within
author
investig
malaria
infect
associ
needl
injuri
usag
contamin
syring
also
report
japan
sinc
first
report
nine
case
malaria
among
drug
user
share
syring
otsuru
kamo
world
war
ii
mani
peopl
includ
veteran
homeless
jobless
indulg
intox
drug
narcot
sometim
sell
blood
act
desper
consequ
spread
malaria
parasit
morishita
summar
syringeassoci
malaria
case
among
peopl
first
nosocomi
malaria
case
nurs
probabl
transmit
accident
needl
injuri
falciparum
malaria
patient
take
care
hospit
amano
et
al
chloroquin
mg
sulformethoxin
mg
pyrimethamin
mg
treatment
administ
stomach
tube
fell
coma
could
save
life
anoth
needleassoci
falciparum
malaria
case
report
male
success
treat
cure
kimura
et
al
iatrogen
malaria
report
japan
transmit
exampl
nonsteril
surgic
oper
contamin
cathet
hypnozoiteinfect
liver
transplant
socal
laboratori
malaria
may
happen
among
research
cultiv
p
falciparum
parasit
never
report
japan
either
halofantrin
report
effect
sinc
involv
patient
countri
particularli
treatment
multidrugresist
malaria
world
chemic
structur
quit
uniqu
close
relat
antimalari
first
case
malaria
success
treat
halofantrin
japan
report
pakistani
male
suffer
p
vivax
malaria
yodonawa
et
al
parasit
clearanc
rapid
fever
drop
dramat
advers
reaction
caus
drug
report
except
slight
nausea
follow
case
first
author
sk
present
paper
group
report
total
import
case
success
treat
halofantrin
pf
pv
japanes
male
pf
pm
mix
foreign
femal
masuda
et
al
kano
et
al
obana
et
al
kano
suzuki
first
experienc
recrudesc
falciparum
malaria
treatment
halofantrin
order
meet
resist
establish
vitro
halofantrin
suscept
test
shikado
et
al
form
opinion
result
experi
halofantrin
effect
safe
toler
treatment
speci
malaria
howev
clinic
studi
involv
patient
thaimyanmar
border
reveal
cardiac
effect
halofantrin
includ
one
sudden
death
treatment
nosten
et
al
spontan
report
seriou
ventricular
dysrythmiasi
prolong
qt
interv
attempt
monitor
ecg
treat
patient
halofantrin
institut
treatment
two
japanes
import
malaria
case
po
male
year
old
pv
male
year
old
inform
consent
monitor
ecg
consequ
found
qt
interv
slightli
prolong
unaffect
qr
interv
symptom
sign
observ
cardiac
system
ecg
find
kano
announc
drug
alert
halofantrin
condit
describ
doctor
abid
care
studi
individu
japanes
patient
confirm
efficaci
toler
need
halofantrin
gener
use
japan
artemeth
chemic
extract
herb
qinghao
artemisia
annua
l
use
year
chines
tradit
medicin
treatment
fever
malaria
drug
report
particularli
use
treatment
sever
complic
falciparum
malaria
first
case
sever
malaria
treat
artemeth
im
japan
japanes
male
travel
africa
kano
et
al
admiss
alreadi
comatos
parasitemia
artemeth
im
administ
intramuscularli
patient
inform
consent
famili
success
cure
consequ
sequela
day
artemisinin
deriv
distribut
limit
author
china
drug
kindli
given
first
author
sk
second
case
treat
artemeth
im
japan
much
sever
case
patient
mix
infect
falciparum
vivax
malaria
show
p
falciparum
parasitemia
hosaka
et
al
deep
coma
improv
soon
administr
drug
understand
artemisinin
deriv
effect
experiment
studi
conduct
morpholog
p
falciparum
owl
monkey
confirm
effect
artemeth
kawai
et
al
variou
regimen
administr
artemisinin
deriv
introduc
japan
use
tablet
suppositori
intramuscular
intraven
fluid
time
alreadi
knew
recrudesc
rate
high
one
artemisinin
deriv
artesun
use
singl
monotherapi
kondou
et
al
anyway
artesun
artemisinin
deriv
offici
regist
use
japan
abovement
research
group
stock
plasmotrim
lactab
artesun
tablet
plasmotrim
rectcap
artesun
suppositori
case
need
treat
sever
complic
malaria
japan
quit
recent
sever
new
data
report
looareesuwan
group
mahidol
univers
thailand
combin
therapi
artesun
iv
follow
mefloquin
quit
effect
treatment
drugresist
malaria
sever
malaria
combin
tri
japan
three
patient
outcom
report
yasuoka
et
al
itoda
et
al
yoshizawa
et
al
trend
action
toward
multidrugresist
malaria
develop
new
combin
therapi
includ
artemisinin
deriv
artemetherlumefantrin
coartem
riamet
one
promis
combin
ishizaki
et
al
accept
gener
use
japan
although
number
japanes
travel
go
abroad
increas
visit
europ
north
america
travel
asian
countri
korea
taiwan
popular
go
african
countri
therefor
chanc
contract
malaria
smaller
japanes
travel
american
european
travel
moreov
number
foreign
travel
come
japan
high
million
compar
franc
million
unit
kingdom
million
introduct
parasit
migrat
popul
may
frequent
visit
friend
rel
primari
concern
japan
nevertheless
fulli
prepar
continu
increas
malaria
patient
particularli
area
drugresist
malaria
endem
total
amount
blood
donat
around
million
year
japan
therefor
appli
estim
incid
transfusiontransmit
malaria
unit
state
million
unit
mungai
et
al
possibl
parasit
contamin
preserv
blood
transfus
japan
may
nil
abid
us
guidelin
blood
donor
select
fact
japanes
guidelin
stricter
us
chanc
transfus
malaria
small
japan
surveil
system
malaria
patient
japan
enforc
mhlw
enact
revis
infecti
diseas
control
law
april
howev
inform
get
survey
augment
obtain
activ
research
group
integr
two
independ
surveil
system
envisag
anoth
problem
solv
drug
preserv
distribut
system
research
group
mhlw
japan
allow
use
fansidar
mephaquin
offici
encourag
research
group
time
fulli
prepar
new
drug
therapi
sever
malaria
case
effort
made
member
research
group
exampl
publish
case
report
guidelin
mhlw
accept
import
introduc
effect
new
drug
signific
chemoprophylaxi
well
recogn
japan
approv
mefloquin
use
mhlw
treatment
also
prophylaxi
physician
encourag
prescrib
drug
intern
travel
still
mani
japanes
physician
confid
tropic
travel
medicin
guidelin
prevent
malaria
use
appropri
drug
establish
soon
possibl
mefloquin
resist
malaria
report
wide
asian
malari
area
inde
alreadi
report
resist
japan
prepar
use
anoth
good
chemoprophylact
regimen
appli
instanc
atovaquoneproguanil
primaquin
doxycyclin
minocyclin
lin
et
al
japan
research
group
travel
medicin
vaccin
develop
drug
develop
field
survey
control
respect
support
grant
japanes
govern
integr
malaria
research
yield
fruit
result
control
import
malaria
case
japan
